Guillaume Barbe

Guillaume Barbe has a diverse work experience in the pharmaceutical industry. Guillaume is currently the VP and Head of Drug Discovery at Valence Discovery since June 2022. Prior to this, they worked at RA Capital Management, where they served as the Executive Director and Head of Chemistry at a stealth Newco from February 2021 to June 2022.

From November 2020 to February 2021, Guillaume worked at Rheos Medicines as the Interim Head of Drug Discovery. Before that, they were the Senior Director and Head of Chemistry at Rheos Medicines from March 2018 to November 2020.

Guillaume also has experience as a Consultant at Third Rock Ventures for a brief period from January 2018 to March 2018. Prior to that, they worked at GSK as the Head of Chemistry in the Tempero DPU from August 2017 to January 2018, and as a Senior Scientific Investigator from July 2015 to August 2017.

Guillaume'searlier experience includes roles at Novartis Institutes for BioMedical Research, where they worked as a Research Investigator III from May 2014 to July 2015, and as a Research Investigator II from December 2010 to May 2014. Guillaume also worked as a Senior Research Chemist at Merck Frosst from April 2009 to October 2010.

Guillaume began their career as a Co-op Student at Pfizer, where they worked in three different roles from 2001 to 2002.

Guillaume Barbe pursued their education in Chemistry, specializing in Organic Chemistry. Guillaume obtained their Bachelor of Science degree from Universite de Sherbrooke between 1999 and 2002. Guillaume then continued their academic journey and completed their Master of Science degree, also in Organic Chemistry, at the same university from 2003 to 2004. In their pursuit of further knowledge and expertise, Guillaume enrolled at Universite de Montreal, where they successfully earned their Ph.D. in Organic Chemistry from 2005 to 2009.